THE GENESIS OF FLORADAPT™
Kaneka has been at the forefront of developing novel probiotic solutions for a variety of health applications. From inception to finished product, Floradapt™ stands alone because of our unique process of developing clinically validated probiotic formulations. Floradapt™ products are based on a mechanistic approach to identify optimal strains for specific health applications. The strain library is a collection of over 1,000 different, wild-type strains strategically sourced from around the world and populations with good health yet little exposure to modern lifestyle and amenities. As a result, our strains are derived from healthy individuals with “conserved microbiomes” that have not lost their health functionality, therefore providing a diverse microbiome which is more adept at achieving better homeostasis. Probiotic researchers frequently see non-conserved microbiomes in western societies, where the diversity of the gut microbiota is reduced because of exposure to antibiotics and antifungals, among other factors. Hosts with conserved microbiomes have abundant, acid-resistant smart strains that can offer superior efficacy for a variety of health applications, including gut, digestion, immunity, infant colic, women’s, and cardiovascular health.
Floradapt™ contains science-based strains for a targeted clinical application, which may be formulated into proprietary products. Our published, randomized, double-blind, placebo-controlled clinical trials utilized actual dosages appropriate for commercial dietary supplement products. What this means for the brand is that the finished dosages are designed to contain the exact amounts, potency, strains, and delivery modality used in the clinical trials.